Omada Health (OMDA) 10-Year Financial Performance & Capital Metrics

OMDA • • Industrial / General

HealthcareHealthcare ITTelehealth & Virtual Care PlatformsSpecialized Telehealth Solutions

AboutOmada Health is a U.S.-based virtual-care provider offering clinically validated programs for chronic conditions like cardiometabolic disease, musculoskeletal care, and behavioral health—delivered digitally between doctor visits.Show more

Revenue $170M +38.3%
EBITDA -$39M +36.9%
Net Income -$47M +30.2%
EPS (Diluted) -0.85 +29.8%
Gross Margin 60.59% +6.3%
EBITDA Margin -22.88% +54.4%
Operating Margin -25.71% +52.2%
Net Margin -27.76% +49.5%
ROE -57.64% -8.7%
ROIC -202.83% +34.1%
Debt/Equity 0.47 +51.1%
Interest Coverage -9.69 +30.9%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Efficient asset utilization: 1.1x turnover

✗Weaknesses

✗Negative free cash flow
✗Trading more than 30% below 52-week high
✗Expensive at 13.5x book value

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-

5Y-

3Y-

TTM-

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM-

EPS CAGR

10Y-

5Y-

3Y-

TTM-

ROCE

10Y Avg-39.44%

5Y Avg-39.44%

3Y Avg-39.44%

Latest-38.25%

Peer Comparison

Specialized Telehealth Solutions

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
VSEEWVSee Health, Inc.	1.52M	0.09	-0.02	78.42%	-85.76%
VSEEVSee Health, Inc.	14.7M	0.44	-0.08	80.74%	-85.76%
MGRXMangoceuticals, Inc.	10.82M	0.66	-0.15	-15.81%	-42.45%	-126.03%		0.02
BEATHeartBeam, Inc.	75.78M	2.20	-3.01			-50.79%
OMDAOmada Health	906.26M	15.65	-18.41	38.29%	-16.82%	-16.98%		0.47
HNGEHinge Health, Inc.	1.66B	43.76	-291.73	33.37%	-3.06%	-2.83%	2.73%	0.03

Profit & Loss

	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	89.19M	122.78M	169.8M
Revenue Growth %	-	0.38%	0.38%
Cost of Goods Sold+	46.39M	52.81M	66.92M
COGS % of Revenue	0.52%	0.43%	0.39%
Gross Profit+	42.79M	69.97M	102.88M
Gross Margin %	0.48%	0.57%	0.61%
Gross Profit Growth %	-	0.64%	0.47%
Operating Expenses+	115.14M	135.97M	146.53M
OpEx % of Revenue	1.29%	1.11%	0.86%
Selling, General & Admin	88.97M	102.23M	110.61M
SG&A % of Revenue	1%	0.83%	0.65%
Research & Development	26.17M	33.74M	35.92M
R&D % of Revenue	0.29%	0.27%	0.21%
Other Operating Expenses	0	0	0
Operating Income+	-72.35M	-66M	-43.65M
Operating Margin %	-0.81%	-0.54%	-0.26%
Operating Income Growth %	-	0.09%	0.34%
EBITDA+	-68.02M	-61.55M	-38.85M
EBITDA Margin %	-0.76%	-0.5%	-0.23%
EBITDA Growth %	-	0.1%	0.37%
D&A (Non-Cash Add-back)	4.33M	4.45M	4.8M
EBIT	-68.32M	-62.81M	-42.63M
Net Interest Income+	-2M	1.07M	-3.7M
Interest Income	2.2M	5.78M	805K
Interest Expense	4.2M	4.71M	4.51M
Other Income/Expense	-168K	-1.51M	-3.48M
Pretax Income+	-72.52M	-67.51M	-47.14M
Pretax Margin %	-0.81%	-0.55%	-0.28%
Income Tax+	0	0	0
Effective Tax Rate %	1%	1%	1%
Net Income+	-72.52M	-67.51M	-47.14M
Net Margin %	-0.81%	-0.55%	-0.28%
Net Income Growth %	-	0.07%	0.3%
Net Income (Continuing)	-72.52M	-67.51M	-47.14M
Discontinued Operations	0	0	0
Minority Interest	0	0	0
EPS (Diluted)+	-1.30	-1.21	-0.85
EPS Growth %	-	0.07%	0.3%
EPS (Basic)	-1.30	-1.21	-0.85
Diluted Shares Outstanding	55.74M	55.74M	55.74M
Basic Shares Outstanding	55.74M	55.74M	55.74M
Dividend Payout Ratio	-	-	-

Balance Sheet

	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	188.56M	142.88M	113.06M
Cash & Short-Term Investments	168.12M	115.64M	76.39M
Cash Only	168.12M	115.64M	76.39M
Short-Term Investments	0	0	0
Accounts Receivable	11.67M	16.44M	23.92M
Days Sales Outstanding	47.75	48.87	51.42
Inventory	3.54M	3.61M	3.3M
Days Inventory Outstanding	27.85	24.98	17.98
Other Current Assets	2.26M	3.91M	5.16M
Total Non-Current Assets+	33.24M	32.2M	37.83M
Property, Plant & Equipment	6.06M	5.6M	6.07M
Fixed Asset Turnover	14.71x	21.93x	27.96x
Goodwill	13.24M	13.24M	13.24M
Intangible Assets	8.31M	6.27M	4.26M
Long-Term Investments	0	0	0
Other Non-Current Assets	5.63M	7.09M	14.26M
Total Assets+	221.8M	175.08M	150.89M
Asset Turnover	0.40x	0.70x	1.13x
Asset Growth %	-	-0.21%	-0.14%
Total Current Liabilities+	34.51M	43.79M	53.95M
Accounts Payable	4.11M	3.62M	4.17M
Days Payables Outstanding	32.31	25.03	22.73
Short-Term Debt	0	0	0
Deferred Revenue (Current)	1000K	1000K	1000K
Other Current Liabilities	9.99M	15.49M	21.12M
Current Ratio	5.46x	3.26x	2.10x
Quick Ratio	5.36x	3.18x	2.03x
Cash Conversion Cycle	43.29	48.82	46.66
Total Non-Current Liabilities+	31.68M	32.37M	32.31M
Long-Term Debt	28.89M	29.38M	29.77M
Capital Lease Obligations	1.27M	411K	0
Deferred Tax Liabilities	0	0	0
Other Non-Current Liabilities	1.52M	2.58M	2.54M
Total Liabilities	66.19M	76.16M	86.26M
Total Debt+	30.81M	30.58M	30.19M
Net Debt	-137.31M	-85.06M	-46.21M
Debt / Equity	0.20x	0.31x	0.47x
Debt / EBITDA	-	-	-
Net Debt / EBITDA	-	-	-
Interest Coverage	-17.22x	-14.03x	-9.69x
Total Equity+	155.6M	98.92M	64.63M
Equity Growth %	-	-0.36%	-0.35%
Book Value per Share	2.79	1.77	1.16
Total Shareholders' Equity	155.6M	98.92M	64.63M
Common Stock	21K	7K	8K
Retained Earnings	-329.32M	-396.83M	-443.97M
Treasury Stock	0	0	0
Accumulated OCI	0	0	0
Minority Interest	0	0	0

Cash Flow

	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	-68.98M	-49.74M	-34.18M
Operating CF Margin %	-0.77%	-0.41%	-0.2%
Operating CF Growth %	-	0.28%	0.31%
Net Income	-72.52M	-67.51M	-47.14M
Depreciation & Amortization	4.33M	4.45M	4.8M
Stock-Based Compensation	6.65M	8.74M	9.42M
Deferred Taxes	0	0	0
Other Non-Cash Items	1.7M	6.08M	5.3M
Working Capital Changes	-9.14M	-1.5M	-6.57M
Change in Receivables	-3.93M	-5.34M	-8.8M
Change in Inventory	-1.95M	-74K	318K
Change in Payables	-4.99M	-286K	399K
Cash from Investing+	-2.72M	-2.92M	-3.86M
Capital Expenditures	-720K	-416K	-596K
CapEx % of Revenue	0.01%	0%	0%
Acquisitions	-	-	-
Investments	-	-	-
Other Investing	-2M	-2.5M	-3.27M
Cash from Financing+	16.32M	179K	-1.21M
Debt Issued (Net)	-	-	-
Equity Issued (Net)	-	-	-
Dividends Paid	0	0	0
Share Repurchases	-	-	-
Other Financing	1.27M	-2.54M	-4.54M
Net Change in Cash	-	-	-
Free Cash Flow+	-71.7M	-52.66M	-38.04M
FCF Margin %	-0.8%	-0.43%	-0.22%
FCF Growth %	-	0.27%	0.28%
FCF per Share	-1.29	-0.94	-0.68
FCF Conversion (FCF/Net Income)	0.95x	0.74x	0.73x
Interest Paid	3.61M	4.09M	3.85M
Taxes Paid	0	0	0

Key Ratios

Metric	2022	2023	2024
Return on Equity (ROE)	-46.6%	-53.05%	-57.64%
Return on Invested Capital (ROIC)	-	-307.92%	-202.83%
Gross Margin	47.98%	56.99%	60.59%
Net Margin	-81.31%	-54.98%	-27.76%
Debt / Equity	0.20x	0.31x	0.47x
Interest Coverage	-17.22x	-14.03x	-9.69x
FCF Conversion	0.95x	0.74x	0.73x
Revenue Growth	-	37.67%	38.29%

Frequently Asked Questions

Growth & Financials

Omada Health (OMDA) reported $219.5M in revenue for fiscal year 2024. This represents a 146% increase from $89.2M in 2022.

Omada Health (OMDA) grew revenue by 38.3% over the past year. This is strong growth.

Omada Health (OMDA) reported a net loss of $36.9M for fiscal year 2024.

Dividend & Returns

Omada Health (OMDA) has a return on equity (ROE) of -57.6%. Negative ROE indicates the company is unprofitable.

Omada Health (OMDA) had negative free cash flow of $26.6M in fiscal year 2024, likely due to heavy capital investments.

← Back to Screener